Literature DB >> 6695948

Acute renal failure in patients with multiple myeloma.

D J Cohen, W H Sherman, E F Osserman, G B Appel.   

Abstract

In the past, patients with multiple myeloma and acute renal failure have had a poor prognosis. Few patients recovered renal function and fewer still survived for prolonged time periods. This report describes the course of 10 patients with multiple myeloma and true acute renal failure treated during the decade 1970 to 1980, and reviews recent reports concerning this association. The use of radiographic contrast agents is no longer the primary predisposing factor to acute renal failure in the myeloma population. Rather, infection, hypercalcemia, and dehydration in the presence of light chain excretion are the major conditions precipitating the renal failure. Despite severe renal failure requiring dialysis, many patients may regain good renal function. Factors associated with a good or poor prognosis in this population are reviewed. The prognosis in patients with myeloma and acute renal failure has greatly improved in recent years, and prolonged survival may occur.

Entities:  

Mesh:

Year:  1984        PMID: 6695948     DOI: 10.1016/0002-9343(84)90781-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Continuous ambulatory peritoneal dialysis in patients with renal failure due to multiple myeloma.

Authors:  Mufazzal Ahmad
Journal:  Int Urol Nephrol       Date:  2007-01-13       Impact factor: 2.370

2.  Dialysis treatment in multiple myeloma.

Authors:  I Taraba; A Hering
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

3.  Calcitriol directly sensitizes renal tubular cells to ATP-depletion- and iron-mediated attack.

Authors:  R A Zager
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  Incidence of Contrast-Induced Nephropathy in Patients with Multiple Myeloma Undergoing Contrast-Enhanced Procedures.

Authors:  Maeve P Crowley; Vinitha N Prabhakaran; Oonagh M Gilligan
Journal:  Pathol Oncol Res       Date:  2017-09-13       Impact factor: 3.201

Review 5.  [What is reliable in prevention of contrast medium-induced nephropathy?].

Authors:  C B Friedrichsohn; W Riegel; H Köhler
Journal:  Med Klin (Munich)       Date:  1997-06-15

Review 6.  Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention.

Authors:  Michele Andreucci; Richard Solomon; Adis Tasanarong
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

7.  Clinical profile of kidney involvement preceding diagnosis of multiple myeloma; a single center experience.

Authors:  Manish R Balwani; Manoj R Gumber; Pankaj R Shah; Vivek B Kute; Himanshu V Patel; Divyesh P Engineer; Dinesh N Gera; Umesh Godhani; Rajesh Singh Gautam; Hargovind L Trivedi
Journal:  J Nephropharmacol       Date:  2015-03-29

Review 8.  Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Michele Bertolotto; Henrik S Thomsen; Gabriele Pozzato; Donatella Ugolini; Marie-France Bellin; Georg Bongartz; Olivier Clement; Gertraud Heinz-Peer; Aart van der Molen; Peter Reimer; Judith A W Webb
Journal:  Eur Radiol       Date:  2017-08-30       Impact factor: 5.315

Review 9.  Pathogenesis of renal failure in multiple myeloma: any role of contrast media?

Authors:  Michele Mussap; Giampaolo Merlini
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

Review 10.  Acute kidney injury by radiographic contrast media: pathogenesis and prevention.

Authors:  Michele Andreucci; Teresa Faga; Antonio Pisani; Massimo Sabbatini; Ashour Michael
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.